C Oncology R & D And Marketing Strategy

At present, most of homemade anticancer drug, excluding traditional Chinese medicines and immunity products, are imitated preparation. Due to the patent protection on many medicines, the clinical demand can be only satisfied by imported products. Now, our strategy on anticancer drug is as follow: on one hand, to develop new medicine on one hand; and on the other hand to imitate some good clinical effect products which have lost patent protection urgently.With China's accession to the WTO and the macro-control by our government, the rearrangement in the market of domestic medicine has started and the market is getting more organized. Under this circumstance, enterprises should learn to R&D new anti-cancer products by themselves and establish a marketing team with professional skills on anti-cancer medicine promotion gradually.The essay analyzes and studies problems Company C faced in new products both R&D and marketing. Company C is a production enterprise which specializes on anti-cancer medicines and has made success on paten product P-10 injection by marketing concept of Science drives sales.According to this case, I assumed that all enterprises specializing on anti-cancer field who are eager to be impregnable in the market competition should concentrate on new products R&D for future and optimize presenting marketing mode which will helps the enterprise get rid of current problems and get better position in long term strategy.